Correlation of microsatellite status, proliferation, apoptotic and selected immunohistochemical markers in colorectal carcinoma studied with tissue microarray

Polish Journal of Pathology

Volumn 57, Issue 2, 2006, Pages 105-111

  Okoń, Krzysztof ^a   Demczuk, Sergiusz ^a   Klimkowska, Agnieszka ^a   Wójcik, Piotr ^a   Osuch, Czesław ^a   Papla, Bolesław ^a   Stachura, Jerzy ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P16; PROTEIN P53; SURVIVIN; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; APOPTOSIS; ARTICLE; CAPILLARY ELECTROPHORESIS; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748936130     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. American Joint Committee on cancer: Colon and rectum. In: AJCC Cancer Staging Manual. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, eds. Springer-Verlang 2002, 113-124.
2. Arnold CN, Goel A, Compton C, Marcus V et al: Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer. Cancer Biol Ther 2004, 3, 73-78.
3. Boland CR, Thibodeau SN, Hamilton SR, Sidrausky D et al: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58, 5248-5257.
4. Carethers JM, Smith EJ, Behling CA, Nguyen L et al: Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004, 126, 394-401.
5. Chapusot C, Martin L, Puig PL, Ponnelle T et al: What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol 2004, 28, 1553-1559.
6. Choi S, Lee KJ, Bae Y, Min K et al: Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002, 8, 2311-2322.
7. Elsaleh H, Powell B, McCaul K, Grieu F et al: P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 2001, 7, 1343-1349.
8. Emterling A, Wallin A, Arbman G, Sun X: Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer. Ann Oncol 2004, 15, 242-246.
9. Haddad R, Ogilvie RT, Croitoru M, Muniz V et al: Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Ann Surg Oncol 2004, 11, 977-982.
10. Hamilton SR, Rubio CA, Vogelstein B, Sobin LH et al: Carcinoma of the colon and rectum. In: Hamilton S, Aaltonen LA, eds.: World Health Organisation classification of tumors. Pathology and genetics of tumours of the digestive system. IARC Press, Lyon 2000, 105-119.
11. Herman JG, Umar A, Polyak K, Graff JR et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998, 95, 6870-6875.
12. Iida A, Yamaguchi A, Hirose K: Telomerase activity in colorectal cancer and its relationship to bcl-2 expression. J Surg Oncol 2000, 73, 219-223.
13. Jass JR, Biden KG, Cummings MC, Simms LA et al: Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 1999, 52, 455-460.
14. Johannsdottir JT, Bergthorsson JT, Gretarsdottir S, Kristjansson AK et al: Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables. Anticancer Res 1999, 19, 1821-1826.
15. Jover R, Paya A, Alenda C, Poveda MJ et al: Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. Am J Clin Pathol 2004, 122, 389-394.
16. Kakar S, Aksoy S, Burgart LJ, Smyrk TC: Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival. Mod Pathol 2004, 17, 696-700.
17. Ko JM, Cheung MH, Kwan MW, Wong CM et al: Genomic instability and alterations in Apc, Mcc and Dec in Hong Kong patients with colorectal carcinoma. Int J Cancer 1999, 84, 404-409.
18. Kononen J, Bubendorf L, Kallioniemi A, Borlund M et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4, 844-847.
19. Leahy DT, Mulcahy HE, O'Donoghue DP, Parfrey NA: bcl-2 protein expression is associated with better prognosis in colorectal cancer. Histopathology 1999, 35, 360-367.
20. Leug SY, Yuen ST, Chung LP, Chu KM et al: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999, 59, 159-164.
21. Lim S, Jeong S, Lee MR, Ku J et al: Prognostic significance of microsatellite instability in sporadic colorectal cancer. Int J Colorectal Dis 2004, 19, 533-537.
22. Lino H, Jass JR, Simms LA, Young J et al: DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?. J Clin Pathol 1999, 52, 5-9.
23. Lipton LR, Johnson V, Cummings C, Fisher S et al: Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004, 22, 4934-4943.
24. Marcus VA, Madlensky L, Gryfe R, Kim H et al: Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999, 23, 1248-1255.
25. Masubuchi S, Konishi F, Togashi K, Okamoto T et al: The significance of microsatellite instability in predicting the development of metachronous multiple colorectal carcinomas in patients with nonfamilial colorectal carcinoma. Cancer 1999, 85, 1917-1924.
26. Mori Y, Selaru FM, Sato F, Yin J et al: The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res 2003, 63, 4577-4582.
27. Mueller J, Mueller E, Hoepner I, Jutting J et al: Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study. J Pathol 1996, 180, 259-265.
28. Ofner D, Riehemann K, Maier H, Riedmann B et al: Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer 1995, 72, 981-985.
29. Okoń K, Zazula M, Rudzki Z, Papla B et al: CDX-2 expression is reduced in colorectal carcinomas with solid growth pattern and proximal location, but is largely independent of MSI status. Pol J Pathol 2004, 55, 9-14.
30. Packeisen J, Korsching E, Herbst H, Boecker W et al: Demystified tissue microarray technology. Mol Pathol 2003, 56, 198-204.
31. Phillips SM, Banerjea A, Feakins R, Li SR et al: Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg 2004, 91, 469-475.
32. Rodrigues NR, Rowan A, Smith ME, Kerr IB et al: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990, 87, 7555-7559.
33. Rosai G: Large bowel - colectomy for tumor. In: Ackerman's Surgical Pathology. Rosai G, ed. Mosby St. Luis 1996, 2671-2672.
34. Smyrk TC, Watson P, Kaul K, Lynch HT: Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 2001, 91, 2417-2422.
35. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992, 66, 558-562.
36. Tan H, Liu J, Wu S, Luo H: Expression of a novel apoptosis inhibitor-survivin in colorectal carcinoma. World J Gastroenterol 2005, 11, 4689-4692.
37. Trojan J, Brieger A, Raedle J, Weber N et al: BAX and caspase-5 frameshift mutations and spontaneous apoptosis in colorectal cancer with microsatellite instability. Int J Colorectal Dis 2004, 19, 538-544.
38. Tu SP, Cui JT, Liston P, Huajiang X et al: Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant. Gastroenterology 2005, 128, 361-375.
39. Whitehall VL, Walsh MD, Young J, Leggett BA et al: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 2001, 61, 827-830.
40. Wright CM, Dent OF, Newland RC, Barker M et al: Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma. Gut 2005, 54, 103-108.
41. Yamamoto T, Manome Y, Nakamura M, Tanigawa N: Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur J Cancer 2002, 38, 2316-2324.
42. Zauber P, Sabbath-Solitare M, Marotta S, Zauber A et al: Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual. J Clin Pathol 2004, 57, 1084-1088.
43. Zhang T, Fields JZ, Ehrlich SM, Boman BM: The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells. J Pharmacol Exp Ther 2004, 308, 434-437.